3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Multiple Myeloma
12
Ovarian Neoplasms
9
Recurrence
8
Lymphoma, B-Cell
8
Pancreatic Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma
7
Hodgkin Disease
7
Burkitt Lymphoma
7
Colorectal Neoplasms
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Biphenotypic, Acute
5
Stomach Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia
4
Hematologic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urogenital Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Follicular
3
Leukemia, B-Cell
3
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
fludarabine
×
30 days
×
Clear all
No trials found.